InvestSMART

THC Global Group Limited (ASX: THC) - Announcements

Current share price for THC : $0.230 0.005 (2.13%)+

ASX company news and announcements for THC Global Group Limited (THC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All THC Global Group Limited (THC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than THC Global Group Limited (THC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for THC Global Group Limited (THC)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$44 Successful Share Placement and SPP 14 Dec 2017 10:30AM $0.790 $0.230 fallen by 70.89%
$44 Trading Halt 12 Dec 2017 9:34AM $0.790 $0.230 fallen by 70.89%
$44 Release of Shares from Escrow 8 Dec 2017 4:39PM $0.755 $0.230 fallen by 69.54%
$44 THC Signs Licensing with National Access Clinics Canada 7 Dec 2017 9:35AM $0.735 $0.230 fallen by 68.71%
$44 Appendix 3B - Escrow Release 30 Nov 2017 8:51AM $0.850 $0.230 fallen by 72.94%
$44 Shareholder Update 29 Nov 2017 9:46AM $0.900 $0.230 fallen by 74.44%
$44 Appointment of Chief Commercial Officer 21 Nov 2017 9:21AM $0.950 $0.230 fallen by 75.79%
$44 Entering Partnership with Israeli Cannabis Pioneer BOLPharma 20 Nov 2017 9:10AM $0.850 $0.230 fallen by 72.94%
$44 Release of Shares from Escrow 16 Nov 2017 5:54PM $0.650 $0.230 fallen by 64.62%
$44 Distribution Agreement Signed with Major European Supplier 15 Nov 2017 9:51AM $0.525 $0.230 fallen by 56.19%
$44 Investor Presentation 13 Nov 2017 8:56AM $0.355 $0.230 fallen by 35.21%
$44 Canndeo Granted Medicinal Cannabis License by the ODC 30 Oct 2017 9:18AM $0.225 $0.230 risen by 2.22%
$44 September Quarterly Activities Report 27 Oct 2017 1:29PM $0.200 $0.230 risen by 15%
$44 Appendix 4C - September Quarterly 27 Oct 2017 1:25PM $0.200 $0.230 risen by 15%
$44 Final Director's Interest Notice - J Hall 19 Oct 2017 3:30PM $0.255 $0.230 fallen by 9.80%
$44 Group CEO Appointment, New Chairman and Board Changes 19 Oct 2017 10:44AM $0.230 $0.230 fallen by 0%
$44 Executive Team - International Business and Prospects Report 5 Sep 2017 9:18AM $0.280 $0.230 fallen by 17.86%
$44 Medicinal Cannabis Prescription and Dispensing Portal 1 Sep 2017 9:59AM $0.270 $0.230 fallen by 14.81%
$44 2017 Half Yearly Report and Accounts 31 Aug 2017 11:04AM $0.275 $0.230 fallen by 16.36%
$44 Chief Financial Officer and Company Secretary Appointment 16 Aug 2017 12:32AM $0.310 $0.230 fallen by 25.81%
$44 Quarterly Business Review 2 Aug 2017 11:10AM $0.250 $0.230 fallen by 8%
$44 Appendix 4C 1 Aug 2017 9:18AM $0.250 $0.230 fallen by 8%
$44 Medicinal Cannabis Licences - Update 13 Jul 2017 11:00AM $0.280 $0.230 fallen by 17.86%
$44 Medicinal Cannabis Research Licence Granted 11 Jul 2017 8:46AM $0.315 $0.230 fallen by 26.98%
$44 Trading Halt 7 Jul 2017 9:43AM $0.315 $0.230 fallen by 26.98%

251 - 275 of 307 results

Page 11 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.